INFERGEN Side Effects

7023945-5 | Decreased Appetite, Depression, Headache, Malaise, Nausea
on Sep 17, 2010 Female patient from UNITED STATES , weighting 218.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, depression (What is depression?), headache (What is headache?), malaise, nausea (What is nausea?). Infergen dosage: 15 Ug Qd Subcutaneous. During the same period patient was treated with RIBAVIRIN (600 Mg Bid Oral) (View Ribavirin Review and Ribavirin Label ), ONGLYZA (View Onglyza Review and Onglyza Label ), WELCHOL (View Welchol Review and Welchol Label ), PLAVIX (View Plavix Review and Plavix Label ).

7023449-X | Fatigue, Insomnia, Muscle Spasms, Nausea
Patient was taking Infergen (View Usage). Patient had the following side effects: fatigue, insomnia, muscle spasms, nausea (What is nausea?) on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 180.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Infergen dosage: 15 Ug Qd Subcutaneous. During the same period patient was treated with RIBAVIRIN (600 Mg Bid Oral) (View Ribavirin Review and Ribavirin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

7021554-5 | Abdominal Pain, Anaemia, Asthenia, Back Pain, Cough, Impaired Driving Ability, Pain In Extremity, Pleural Effusion
Adverse event was reported on Sep 17, 2010 by a Female patient taking Infergen (View Usage) (Dosage: (15 Ug Od Subcutaneous)) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 214.0 lb, After Infergen was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, asthenia, back pain (What is back pain?), cough, impaired driving ability, pain in extremity, pleural effusion. During the same period patient was treated with RIBAVIRIN ((600 Mg Bid Oral)) (View Ribavirin Review and Ribavirin Label ), PEGASYS ((180 Ug, 180 Mcg)) (View Pegasys Review and Pegasys Label ), LASIX (View Lasix Review and Lasix Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), LYRICA (View Lyrica Review and Lyrica Label ), NEXIUM (View Nexium Review and Nexium Label ), AMBIEN (View Ambien Review and Ambien Label ), ROBAXIN (View Robaxin Review and Robaxin Label ).

7003601-X | Agitation, Anxiety, Apraxia, Blood Calcium Decreased, Blood Pressure Increased, Burning Sensation, Cerebrovascular Accident, Confusional State, Decreased Interest
on Sep 07, 2010 Male patient from UNITED STATES , weighting 165.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, anxiety (What is anxiety?), apraxia, blood calcium decreased, blood pressure increased, burning sensation, cerebrovascular accident, confusional state, decreased interest. Infergen dosage: (15 ?g Qd Subcutaneous). During the same period patient was treated with RIBAVIRIN ((1000 Mg, [600 Mg Qam And 400 Mg Qpm] Oral), (df)) (View Ribavirin Review and Ribavirin Label ), PEGASYS ((df)) (View Pegasys Review and Pegasys Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), VARDENAFIL HYDROCHLORIDE (LEVITRA) (View Vardenafil Hydrochloride (levitra) Review and Vardenafil Hydrochloride (levitra) Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).


6942746-7 | Anaemia, Libido Decreased, Weight Decreased
on Aug 12, 2010 Male patient from UNITED STATES , 59 years of age, was treated with Infergen (View Usage). Patient had the following side effects: anaemia, libido decreased, weight decreased. Infergen dosage: 15 Ug. During the same period patient was treated with RIBAVARIN (1200 Mg) (View Ribavarin Review and Ribavarin Label ).

6937522-5 | Haematocrit Decreased, Haemoglobin Decreased
Patient was taking Infergen (View Usage). After Infergen was administered, patient had the following side effects: haematocrit decreased, haemoglobin decreased on Aug 23, 2010 from UNITED STATES Additional patient health information: Female patient , 51 years of age, weighting 235.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Infergen dosage: 9mcg -0.3ml- Three Times A Week Sq. During the same period patient was treated with RIBASPHERE (200mg Twice Daily Po) (View Ribasphere Review and Ribasphere Label ), PROCRIT (View Procrit Review and Procrit Label ). Patient was hospitalized.

6914686-0 | Eschar, Injection Site Erosion, Injection Site Erythema, Injection Site Infection, Injection Site Pain, Injection Site Ulcer
Adverse event was reported on Aug 05, 2010 by a Female patient taking Infergen (View Usage) (Dosage: 15mcg Daily Subcutaneous) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 106.9 lb, Patient experienced the following unwanted or unexpected effects: eschar, injection site erosion, injection site erythema, injection site infection, injection site pain, injection site ulcer. Patient was hospitalized.

6860677-8 | Abdominal Pain Upper, Agitation, Anaemia, Blood Glucose Increased, Chest Pain, Decreased Appetite, Depression, Dyspepsia, Emotional Distress
on Jul 01, 2010 Male patient from UNITED STATES , weighting 220.0 lb, was diagnosed with hepatitis c (What is hepatitis c?), hypertension, type 2 diabetes mellitus and was treated with Infergen (View Usage). Patient had the following side effects: abdominal pain upper, agitation, anaemia, blood glucose increased, chest pain (What is chest pain?), decreased appetite, depression (What is depression?), dyspepsia, emotional distress. Infergen dosage: (15 ?g Qd Subcutaneous), (9 ?g Qd Subcutaneous). During the same period patient was treated with RIBASPHERE ((600 Mg Bid Oral), (600 Mg, [200 Mg Qam And 400 Mg Qpm] Oral)) (View Ribasphere Review and Ribasphere Label ), LISINOPRIL ((df Oral)) (View Lisinopril Review and Lisinopril Label ), METFORMIN HCL ((500 Mg Bid Oral)) (View Metformin Hcl Review and Metformin Hcl Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ).

6819051-2 | Abdominal Discomfort, Abdominal Distension, Abdominal Pain Upper, Agitation, Anaemia, Blood Creatinine Increased, Blood Glucose Increased, Chest Pain, Cough
on Jun 16, 2010 Male patient from UNITED STATES , weighting 220.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). After Infergen was administered, patient had the following side effects: abdominal discomfort, abdominal distension, abdominal pain upper, agitation, anaemia, blood creatinine increased, blood glucose increased, chest pain (What is chest pain?), cough. Infergen dosage: 15 Ug Qd Subcutaneous, 9 Ug Qd Subcutaneous. During the same period patient was treated with RIBASPHERE (600 Mg Bid Oral, 200 Mg Qam And 400 Mg Qpm, Oral) (View Ribasphere Review and Ribasphere Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6813312-9 | Abdominal Discomfort, Abdominal Distension, Abdominal Pain Upper, Agitation, Anaemia, Blood Creatinine Increased, Blood Glucose Increased, Chest Pain, Condition Aggravated
Patient was taking Infergen (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, abdominal distension, abdominal pain upper, agitation, anaemia, blood creatinine increased, blood glucose increased, chest pain (What is chest pain?), condition aggravated on Jun 14, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 220.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Infergen dosage: 15 Ug Qd, Subcutaneous, 9 Ug Qd, Subcutaneous. During the same period patient was treated with RIBASPHERE (600 Mg Bid, Oral, 600 Mg, [200 Mg Qam And 400 Mg Qpm], Oral) (View Ribasphere Review and Ribasphere Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6809439-8 | Bone Pain, Decreased Appetite, Depression, Fatigue, Hyperhidrosis, Influenza Like Illness, Listless, Nausea, Pain Of Skin
Adverse event was reported on Jun 07, 2010 by a Male patient taking Infergen (View Usage) (Dosage: 15 Ug Qd Subcutaneous) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 250.0 lb, Patient had the following side effects: bone pain, decreased appetite, depression (What is depression?), fatigue, hyperhidrosis, influenza like illness, listless, nausea (What is nausea?), pain of skin. During the same period patient was treated with RIBAVIRIN (600 Ug Bid Oral) (View Ribavirin Review and Ribavirin Label ).

6734643-7 | Alanine Aminotransferase Increased, Anaemia, Angiogram Abnormal, Arthralgia, Back Pain, Depression, Gastrooesophageal Reflux Disease, Glomerular Filtration Rate Decreased, Haematocrit Decreased
on May 04, 2010 Female patient from UNITED STATES , weighting 121.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). After Infergen was administered, patient had the following side effects: alanine aminotransferase increased, anaemia, angiogram abnormal, arthralgia, back pain (What is back pain?), depression (What is depression?), gastrooesophageal reflux disease, glomerular filtration rate decreased, haematocrit decreased. Infergen dosage: . During the same period patient was treated with RIBAPAK 200 MG (NOT SPECIFIED) (View Ribapak 200 Mg (not Specified) Review and Ribapak 200 Mg (not Specified) Label ), PEGASYS (Df) (View Pegasys Review and Pegasys Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), AROMASIN (View Aromasin Review and Aromasin Label ).

6724821-5 | Ammonia Increased, Liver Disorder, Pancreatitis Acute
on May 13, 2010 Female patient from UNITED STATES , weighting 111.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). Patient experienced the following unwanted or unexpected effects: ammonia increased, liver disorder, pancreatitis acute. Infergen dosage: 15mcg Once A Day Sq. During the same period patient was treated with RIBAVIRIN (2 Caps Twice A Day Po) (View Ribavirin Review and Ribavirin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MILK THISTLE (View Milk Thistle Review and Milk Thistle Label ), VERAMYST (View Veramyst Review and Veramyst Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), PREMARIN (View Premarin Review and Premarin Label ). Patient was hospitalized.

6697327-X | Balance Disorder, Bipolar Disorder, Blood Thyroid Stimulating Hormone Increased, Confusional State, Depression, Disorientation, Fall, Haematocrit Decreased, Haemoglobin Decreased
Patient was taking Infergen (View Usage). Patient had the following side effects: balance disorder, bipolar disorder (What is bipolar disorder?), blood thyroid stimulating hormone increased, confusional state, depression (What is depression?), disorientation, fall (What is fall?), haematocrit decreased, haemoglobin decreased on Apr 12, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 200.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Infergen dosage: (15 ?g Qd Subcutaneous). During the same period patient was treated with RIBAVIRIN ((1200 Mg, Daily Oral)) (View Ribavirin Review and Ribavirin Label ), PREZISTA (View Prezista Review and Prezista Label ), NORVIR (View Norvir Review and Norvir Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), EFFEXOR XR (View Effexor Xr Review and Effexor Xr Label ), PAXIL (View Paxil Review and Paxil Label ), DARVOCET N 100 (View Darvocet-n 100 Review and Darvocet-n 100 Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ). Patient was hospitalized and became disabled.

6693335-3 | Bacterial Infection, Body Temperature Increased, Chest Pain, Dyspnoea, Fatigue, Heart Rate Irregular
Adverse event was reported on Apr 07, 2010 by a Male patient taking Infergen (View Usage) (Dosage: 9 ?g Qd Subcutaneous) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 241.0 lb, After Infergen was administered, patient had the following side effects: bacterial infection (What is bacterial infection?), body temperature increased, chest pain (What is chest pain?), dyspnoea, fatigue, heart rate irregular. During the same period patient was treated with RIBAVIRIN (400 Mg Bid Oral) (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6672890-3 | Anxiety, Blood Glucose Increased, Blood Pressure Increased, Chest Pain, Chills, Condition Aggravated, Decreased Appetite, Dyspnoea Exertional
on Mar 22, 2010 Female patient from UNITED STATES , weighting 138.9 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), blood glucose increased, blood pressure increased, chest pain (What is chest pain?), chills, condition aggravated, decreased appetite, dyspnoea exertional. Infergen dosage: (15 Ug Qd Subcutaneous). During the same period patient was treated with RIBAVIRIN ((600 Mg Bid [discrepant; 600 Mg Qam And 400 Mg Qpm Per Hospitalist] Oral), (df)) (View Ribavirin Review and Ribavirin Label ), INTERFERON ((df)) (View Interferon Review and Interferon Label ), PREMARIN (View Premarin Review and Premarin Label ), FIORICET (View Fioricet Review and Fioricet Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), REQUIP (View Requip Review and Requip Label ). Patient was hospitalized.

6667060-9 | Anxiety, Chills, Dizziness, Dyspnoea, Feeling Abnormal, Hallucination, Visual, Headache, Hyperhidrosis, Impaired Work Ability
on Mar 16, 2010 Male patient from UNITED STATES , weighting 200.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). Patient had the following side effects: anxiety (What is anxiety?), chills, dizziness (What is dizziness?), dyspnoea, feeling abnormal, hallucination, visual, headache (What is headache?), hyperhidrosis, impaired work ability. Infergen dosage: 15ug Qd, Subcutaneous. During the same period patient was treated with RIBAVIRIN (1000 Mg, 600 Mg Qam And 400mg Qpm] Oral)) (View Ribavirin Review and Ribavirin Label ), PEGASYS (Df) (View Pegasys Review and Pegasys Label ).

6656704-3 | Bipolar Disorder, Blood Thyroid Stimulating Hormone Increased, Confusional State, Depression, Disorientation, Haematocrit Decreased, Haemoglobin Decreased, Incoherent, Platelet Count Decreased
Patient was taking Infergen (View Usage). After Infergen was administered, patient had the following side effects: bipolar disorder (What is bipolar disorder?), blood thyroid stimulating hormone increased, confusional state, depression (What is depression?), disorientation, haematocrit decreased, haemoglobin decreased, incoherent, platelet count decreased on Jan 25, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 200.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Infergen dosage: 15 ?g Subcutaneous. During the same period patient was treated with RIBAVIRIN (1200 Mg, Daily Oral) (View Ribavirin Review and Ribavirin Label ), PREZISTA (View Prezista Review and Prezista Label ), NORVIR (View Norvir Review and Norvir Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), EFFEXOR XR (View Effexor Xr Review and Effexor Xr Label ), PAXIL (View Paxil Review and Paxil Label ), DARVOCET N 100 (View Darvocet-n 100 Review and Darvocet-n 100 Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ). Patient was hospitalized and became disabled.

6649787-8 | Aspartate Aminotransferase Increased, Blood Amylase Increased, Blood Bilirubin Increased, Blood Calcium Decreased, Blood Creatine Phosphokinase Decreased, Blood Glucose Increased, Blood Sodium Decreased, Blood Urine Present, Chest Pain
Adverse event was reported on Mar 05, 2010 by a Male patient taking Infergen (View Usage) (Dosage: (15 Ug 1c/week Subcutaneous)) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 154.0 lb, Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood amylase increased, blood bilirubin increased, blood calcium decreased, blood creatine phosphokinase decreased, blood glucose increased, blood sodium decreased, blood urine present, chest pain (What is chest pain?). During the same period patient was treated with RIBAVIRIN ((1000 Mg, Daily Oral)) (View Ribavirin Review and Ribavirin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), REGLAN (View Reglan Review and Reglan Label ). Patient was hospitalized.

6632638-5 | Anhedonia, Dyspnoea, Impaired Work Ability, Influenza Like Illness, Mental Disorder, Nausea
on Feb 26, 2010 Male patient from UNITED STATES , weighting 200.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). Patient had the following side effects: anhedonia, dyspnoea, impaired work ability, influenza like illness, mental disorder, nausea (What is nausea?). Infergen dosage: 15 Ug Qd Subcutaneous. During the same period patient was treated with RIBAVIRIN (1000 Mg (600 Mg Qam And 400 Mg Qpm] Oral)) (View Ribavirin Review and Ribavirin Label ), PEGASYS (Df) (View Pegasys Review and Pegasys Label ).

6621910-0 | Asthenia, Hypotension, Pancytopenia, Pyrexia, Sepsis
on Feb 10, 2010 Female patient from UNITED STATES , weighting 137.8 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). After Infergen was administered, patient had the following side effects: asthenia, hypotension, pancytopenia, pyrexia, sepsis (What is sepsis?). Infergen dosage: (15 Ug Qd) Subcutaneous. During the same period patient was treated with RIBAVIRIN ((400 Mg Bid Oral)) (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6619201-7 | Amaurosis Fugax, Cellulitis
Patient was taking Infergen (View Usage). Patient experienced the following unwanted or unexpected effects: amaurosis fugax, cellulitis (What is cellulitis?) on Feb 10, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 159.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Infergen dosage: 15 Ug Qd Subcutaneous. During the same period patient was treated with RIBAVIRIN (400 Mg, Bid Oral) (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6607044-X | Hypertensive Encephalopathy, Treatment Noncompliance
Adverse event was reported on Feb 08, 2010 by a Male patient taking Infergen (View Usage) (Dosage: (df)) was diagnosed with hypertension and. Location: UNITED STATES , 54 years of age, Patient had the following side effects: hypertensive encephalopathy, treatment noncompliance. During the same period patient was treated with RIBAVIRIN ((df)) (View Ribavirin Review and Ribavirin Label ), ANTIHYPERTENSIVES ((df)) (View Antihypertensives Review and Antihypertensives Label ). Patient was hospitalized.

6599878-5 | Balance Disorder, Confusional State, Decreased Appetite, Dizziness, Fatigue, Fluid Intake Reduced, Hypersomnia, Nausea, Pyrexia
on Feb 02, 2010 Male patient from UNITED STATES , weighting 170.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). After Infergen was administered, patient had the following side effects: balance disorder, confusional state, decreased appetite, dizziness (What is dizziness?), fatigue, fluid intake reduced, hypersomnia, nausea (What is nausea?), pyrexia. Infergen dosage: (15 Ug Qd Subcutaneous). During the same period patient was treated with RIBAVIRIN ((1000 Mg, [400 Mg Qam And 600 Mg Qpm] Oral)) (View Ribavirin Review and Ribavirin Label ), B12 VITAMIN (View B12-vitamin Review and B12-vitamin Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), MOBIC (View Mobic Review and Mobic Label ), PROTONIX /01263201/ (View Protonix /01263201/ Review and Protonix /01263201/ Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6551093-7 | Amaurosis Fugax, Cellulitis, Oedema Peripheral
on Jan 08, 2010 Male patient from UNITED STATES , weighting 159.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). Patient experienced the following unwanted or unexpected effects: amaurosis fugax, cellulitis (What is cellulitis?), oedema peripheral. Infergen dosage: (15 Pg Qd). During the same period patient was treated with RIBAVIRIN (400 Mg Bid Oral) (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6539396-3 | Hepatitis C, Kidney Infection, Pruritus, Red Blood Cell Count Decreased, Treatment Noncompliance, White Blood Cell Count Decreased
Patient was taking Infergen (View Usage). Patient had the following side effects: hepatitis c (What is hepatitis c?), kidney infection, pruritus, red blood cell count decreased, treatment noncompliance, white blood cell count decreased on Dec 28, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 125.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Infergen dosage: . During the same period patient was treated with RIBAPAK (NOT SPECIFIED) (View Ribapak (not Specified) Review and Ribapak (not Specified) Label ). Patient was hospitalized.

6539395-1 | Adverse Event, Neutrophil Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Dec 30, 2009 by a Male patient taking Infergen (View Usage) (Dosage: 15 Ug Qd Subcutaneous, 9 Ug Qd) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 233.0 lb, After Infergen was administered, patient had the following side effects: adverse event, neutrophil count decreased, white blood cell count decreased. During the same period patient was treated with RIBAPAK (NOT SPECIFIED) (600 Mg Bid Oral) (View Ribapak (not Specified) Review and Ribapak (not Specified) Label ), PROCRIT /00909301/ (View Procrit /00909301/ Review and Procrit /00909301/ Label ).

6535217-3 | Anaemia, Asthenia, Hypotension, Pancytopenia, Pyrexia, Sepsis
on Dec 22, 2009 Female patient from UNITED STATES , weighting 137.8 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, asthenia, hypotension, pancytopenia, pyrexia, sepsis (What is sepsis?). Infergen dosage: (15 Ug Qd). During the same period patient was treated with RIBAVIRIN ((800 Mg, Daily Oral)) (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6523080-6 | Decreased Appetite, Dysphonia, Nausea, Paranasal Sinus Hypersecretion, Retinal Exudates, Sinusitis Noninfective, Tendonitis, Visual Acuity Reduced, Visual Field Defect
on Dec 07, 2009 Male patient from UNITED STATES , weighting 165.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). Patient had the following side effects: decreased appetite, dysphonia, nausea (What is nausea?), paranasal sinus hypersecretion, retinal exudates, sinusitis noninfective, tendonitis, visual acuity reduced, visual field defect. Infergen dosage: (15 ?g Qd 3x/week Subcutaneous). During the same period patient was treated with RIBAVIRIN (1200 Mg, Daily Oral, (1000 Mg [600 Mg Each Morning And 400 Mg Each Evening] Oral)) (View Ribavirin Review and Ribavirin Label ), HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), REMERON (View Remeron Review and Remeron Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ).

6491011-3 | Anaemia, Fatigue, Insomnia, Leukopenia, Neutropenia
Patient was taking Infergen (View Usage). After Infergen was administered, patient had the following side effects: anaemia, fatigue, insomnia, leukopenia, neutropenia on Nov 05, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 145.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Infergen dosage: 9 Ug Qd Subcutaneous. During the same period patient was treated with RIBAVIRIN ((1000 Mg [400 Mg Qam And 600 Mg Qpm] Oral)) (View Ribavirin Review and Ribavirin Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), VICODIN (View Vicodin Review and Vicodin Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), VALTREX (View Valtrex Review and Valtrex Label ).

6416602-7 | Endophthalmitis, Malaise, Ocular Sarcoidosis, Pyrexia, Renal Failure Acute, Uveitis
Adverse event was reported on Oct 14, 2009 by a Female patient taking Infergen (View Usage) (Dosage: 9 Ug Qd, 9 Ug Qod) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: GERMANY , 49 years of age, Patient experienced the following unwanted or unexpected effects: endophthalmitis, malaise, ocular sarcoidosis, pyrexia, renal failure acute, uveitis. During the same period patient was treated with RIBAVIRIN (Df) (View Ribavirin Review and Ribavirin Label ).

6416255-8 | Amnesia, Anaemia, Dyspnoea, Fatigue, Headache, Hepatitis C Rna Increased, Injection Site Nodule, Injection Site Pain, Injection Site Warmth
on Oct 15, 2009 Male patient from UNITED STATES , weighting 250.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). Patient had the following side effects: amnesia, anaemia, dyspnoea, fatigue, headache (What is headache?), hepatitis c rna increased, injection site nodule, injection site pain, injection site warmth. Infergen dosage: (15 ?g Qd Subcutaneous). During the same period patient was treated with RIBAVIRIN ((600 Mg Bid Oral)) (View Ribavirin Review and Ribavirin Label ).

6381866-5 | Injection Site Infection, Myocardial Infarction
on Sep 17, 2009 Male patient from UNITED STATES , weighting 240.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). After Infergen was administered, patient had the following side effects: injection site infection, myocardial infarction. Infergen dosage: (15 ?g Qd Subcutaneous). During the same period patient was treated with RIBAVIRIN ((400 Mg Bid Oral)) (View Ribavirin Review and Ribavirin Label ).

6378632-3 | Arthralgia, Back Pain, Blood Glucose Increased, Cellulitis, Compartment Syndrome, Deep Vein Thrombosis, Diarrhoea, Fatigue, Injection Site Erythema
Patient was taking Infergen (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, back pain (What is back pain?), blood glucose increased, cellulitis (What is cellulitis?), compartment syndrome, deep vein thrombosis (What is deep vein thrombosis?), diarrhoea, fatigue, injection site erythema on Sep 08, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 190.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Infergen dosage: (15 ?g Qd Subcutaneous). During the same period patient was treated with RIBAVIRIN ((1000 Mg, [400 Mg Qam And 600 Mg Qpm] Oral)) (View Ribavirin Review and Ribavirin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), REGLAN (View Reglan Review and Reglan Label ), NOVOLOG (View Novolog Review and Novolog Label ), LANTUS (View Lantus Review and Lantus Label ), ALTACE (View Altace Review and Altace Label ), INSULIN (View Insulin Review and Insulin Label ), THERAPEUTIC PHLEBOTOMY (View Therapeutic Phlebotomy Review and Therapeutic Phlebotomy Label ). Patient was hospitalized.

6357212-X | Headache, Injection Site Haematoma, Weight Decreased
Adverse event was reported on Sep 02, 2009 by a Male patient taking Infergen (View Usage) (Dosage: 15 ?g Qd Subcutaneous) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 185.0 lb, Patient had the following side effects: headache (What is headache?), injection site haematoma, weight decreased. During the same period patient was treated with RIBAVIRIN (600 Mg Bid Oral) (View Ribavirin Review and Ribavirin Label ), LOTREL (View Lotrel Review and Lotrel Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NEXIUM (View Nexium Review and Nexium Label ).

6354792-5 | Disturbance In Attention, Dizziness, Hypophagia, Injection Site Rash, Loss Of Consciousness, Memory Impairment, Nausea, Weight Decreased
on Sep 01, 2009 Female patient from UNITED STATES , weighting 370.4 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). After Infergen was administered, patient had the following side effects: disturbance in attention, dizziness (What is dizziness?), hypophagia, injection site rash, loss of consciousness, memory impairment, nausea (What is nausea?), weight decreased. Infergen dosage: (15 ?g Qd Subcutaneous). During the same period patient was treated with RIBAVIRIN (600 Mg Bid Oral) (View Ribavirin Review and Ribavirin Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), TRAZODONE (View Trazodone Review and Trazodone Label ), PRILOSEC (View Prilosec Review and Prilosec Label ).

6340068-9 | Disturbance In Attention, Hypophagia, Injection Site Rash, Loss Of Consciousness, Memory Impairment, Nausea, Weight Decreased
on Aug 25, 2009 Female patient from UNITED STATES , weighting 168.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). Patient experienced the following unwanted or unexpected effects: disturbance in attention, hypophagia, injection site rash, loss of consciousness, memory impairment, nausea (What is nausea?), weight decreased. Infergen dosage: 15 ?g Qd Subcutaneous. During the same period patient was treated with RIBAVIRIN (600 Mg Bid Oral) (View Ribavirin Review and Ribavirin Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), TRAZODONE (View Trazodone Review and Trazodone Label ), PRILOSEC (View Prilosec Review and Prilosec Label ).

6335809-0 | Headache, Injection Site Haematoma, Weight Decreased
Patient was taking Infergen (View Usage). Patient had the following side effects: headache (What is headache?), injection site haematoma, weight decreased on Aug 19, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 185.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Infergen dosage: 15 Ug Qd Subcutaneous. During the same period patient was treated with RIBAVIRIN (600 Mg Bid Oral) (View Ribavirin Review and Ribavirin Label ), LOTREL (View Lotrel Review and Lotrel Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NEXIUM (View Nexium Review and Nexium Label ).

6317121-9 | Amnesia, Anaemia, Decreased Appetite, Nausea, Somnolence, Treatment Noncompliance, Weight Decreased, White Blood Cell Count Decreased
Adverse event was reported on Aug 11, 2009 by a Male patient taking Infergen (View Usage) (Dosage: (15 ?g Qd, [missed Injections For Approximately 7 Days] Subcutaneous)) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 158.0 lb, After Infergen was administered, patient had the following side effects: amnesia, anaemia, decreased appetite, nausea (What is nausea?), somnolence, treatment noncompliance, weight decreased, white blood cell count decreased. During the same period patient was treated with RIBAVIRIN ((800 Mg Bid Oral)) (View Ribavirin Review and Ribavirin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), CENTRUM SILVER /01292501/ (View Centrum Silver /01292501/ Review and Centrum Silver /01292501/ Label ), CHOLINE (View Choline Review and Choline Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), VITAMIN B12 /00056201/ (View Vitamin B12 /00056201/ Review and Vitamin B12 /00056201/ Label ). Patient was hospitalized.

6315711-0 | Anger, Asthenia, Back Pain, Cardiac Fibrillation, Dialysis, Diarrhoea, Dizziness, Hypotension, Influenza Like Illness
on Aug 07, 2009 Male patient from UNITED STATES , weighting 230.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). Patient experienced the following unwanted or unexpected effects: anger, asthenia, back pain (What is back pain?), cardiac fibrillation, dialysis (What is dialysis?), diarrhoea, dizziness (What is dizziness?), hypotension, influenza like illness. Infergen dosage: 15 Ug Qd, [placed On Hold 24-jul-2009] Subcutaneous. During the same period patient was treated with RIBAVIRIN (Mg Bid Oral) (View Ribavirin Review and Ribavirin Label ), AMBIEN (View Ambien Review and Ambien Label ). Patient was hospitalized.

6315709-2 | Amnesia, Fatigue, Injection Site Pain, Injection Site Swelling, Injection Site Warmth
on Aug 05, 2009 Male patient from UNITED STATES , weighting 250.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). Patient had the following side effects: amnesia, fatigue, injection site pain, injection site swelling, injection site warmth. Infergen dosage: 15 Ug Qd Subcutaneous. During the same period patient was treated with RIBAVIRIN (600 Mg Bid Oral) (View Ribavirin Review and Ribavirin Label ).

6304551-4 | Abasia, Activities Of Daily Living Impaired, Anaemia, Arthralgia, Asthenia, Blood Creatinine Increased, Blood Electrolytes Abnormal, Constipation, Decreased Appetite
Patient was taking Infergen (View Usage). After Infergen was administered, patient had the following side effects: abasia, activities of daily living impaired, anaemia, arthralgia, asthenia, blood creatinine increased, blood electrolytes abnormal, constipation (What is constipation?), decreased appetite on Jul 27, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 727.5 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Infergen dosage: 15 Ug Qd Subcutaneous 15 Ug Qd Subcutaneous. During the same period patient was treated with RIBAVIRIN (200 Mg Bid Oral 200 Mg Bid Oral) (View Ribavirin Review and Ribavirin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACTOS (View Actos Review and Actos Label ), NORVASC (View Norvasc Review and Norvasc Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

6289114-1 | Activities Of Daily Living Impaired, Angioedema, Chest Pain, Chills, Depression, Dyspnoea, Food Allergy, Headache, Hepatic Cirrhosis
Adverse event was reported on Jul 14, 2009 by a Female patient taking Infergen (View Usage) (Dosage: 15 Microgram, Qd Subcutaneous) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 140.0 lb, Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, angioedema, chest pain (What is chest pain?), chills, depression (What is depression?), dyspnoea, food allergy (What is food allergy?), headache (What is headache?), hepatic cirrhosis. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

6284121-7 | Anaemia, Decreased Appetite, Fatigue, Impaired Work Ability, Nausea, Somnolence, Treatment Noncompliance
on Jul 09, 2009 Male patient from UNITED STATES , weighting 158.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). Patient had the following side effects: anaemia, decreased appetite, fatigue, impaired work ability, nausea (What is nausea?), somnolence, treatment noncompliance. Infergen dosage: (15 Ug Qd, [missed Injections For Approximately 7 Days] Subcutaneous. During the same period patient was treated with RIBAVIRIN ((800 Mg Bid Oral)) (View Ribavirin Review and Ribavirin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), CENTRUM SILVER /01292501/ (View Centrum Silver /01292501/ Review and Centrum Silver /01292501/ Label ), CHOLINE (View Choline Review and Choline Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), VITAMIN B12 /00056201/ (View Vitamin B12 /00056201/ Review and Vitamin B12 /00056201/ Label ). Patient was hospitalized.

6279267-3 | Blood Electrolytes Abnormal, Dizziness, Eye Discharge, Insomnia, Listless, Pancreatitis Chronic, Vision Blurred
on Jul 07, 2009 Male patient from UNITED STATES , weighting 330.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). After Infergen was administered, patient had the following side effects: blood electrolytes abnormal, dizziness (What is dizziness?), eye discharge, insomnia, listless, pancreatitis chronic, vision blurred. Infergen dosage: (15 ?g Qd Subcutaneous). During the same period patient was treated with RIBAVIRIN ((200 Mg Bid Oral)) (View Ribavirin Review and Ribavirin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACTOS (View Actos Review and Actos Label ), NORVASC (View Norvasc Review and Norvasc Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

6278514-1 | Arthralgia, Back Pain, Fatigue, Hepatitis B Antibody Abnormal, Injection Site Erythema, Injection Site Rash, Oedema Peripheral, Pyrexia
Patient was taking Infergen (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, back pain (What is back pain?), fatigue, hepatitis b antibody abnormal, injection site erythema, injection site rash, oedema peripheral, pyrexia on Jul 07, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 190.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Infergen dosage: 15 Ug, Qd Subcutaneous. During the same period patient was treated with RIBAVIRIN (1000 Mg, [400 Qam And 600 Mg Qpm] Oral) (View Ribavirin Review and Ribavirin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), NOVOLOG (View Novolog Review and Novolog Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6266434-8 | Fatigue, Treatment Noncompliance, Viral Load Increased, Weight Decreased, White Blood Cell Count Decreased
Adverse event was reported on Jul 01, 2009 by a Female patient taking Infergen (View Usage) (Dosage: See Image) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 100.0 lb, Patient had the following side effects: fatigue, treatment noncompliance, viral load increased, weight decreased, white blood cell count decreased. During the same period patient was treated with RIBAVIRIN (See Image) (View Ribavirin Review and Ribavirin Label ).

6232820-5 | Fatigue, Treatment Noncompliance, Viral Load Increased, Weight Decreased, White Blood Cell Count Decreased
on Jun 03, 2009 Female patient from UNITED STATES , weighting 100.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). After Infergen was administered, patient had the following side effects: fatigue, treatment noncompliance, viral load increased, weight decreased, white blood cell count decreased. Infergen dosage: (15 ?g Qd Subcutaneous), (12 ?g Qd Subcutaneous). During the same period patient was treated with RIBAVIRIN (See Image) (View Ribavirin Review and Ribavirin Label ).

6211915-6 | Alanine Aminotransferase Increased, Ammonia Increased, Aspartate Aminotransferase Increased, Nausea, No Therapeutic Response, Pain, Platelet Count Decreased, Upper Respiratory Tract Infection
on May 18, 2009 Male patient from UNITED STATES , 55 years of age, weighting 216.1 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Infergen (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, ammonia increased, aspartate aminotransferase increased, nausea (What is nausea?), no therapeutic response, pain (What is pain?), platelet count decreased, upper respiratory tract infection. Infergen dosage: (9 Ug Qd Subcutaneous), (12-15 Mcg Daily Subcutaneous), (9 Ug Qd, [discontinued For 2 Weeks, Then St. During the same period patient was treated with RIBAVIRIN ((200 Mg Bid, [discontinued For 2 Weeks, Then Restarted] Oral)) (View Ribavirin Review and Ribavirin Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ), ALBUTEROL W/IPRATROPIUM (View Albuterol W/ipratropium Review and Albuterol W/ipratropium Label ), AMITRIPTLINE HYDROCHLORIDE TAB (View Amitriptline Hydrochloride Tab Review and Amitriptline Hydrochloride Tab Label ), MIRITAZAPINE (View Miritazapine Review and Miritazapine Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6168244-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Depression, Dizziness, Erythema, Fatigue, Flat Affect, Haematocrit Decreased, Haemoglobin Decreased
Patient was taking Infergen (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, depression (What is depression?), dizziness (What is dizziness?), erythema, fatigue, flat affect, haematocrit decreased, haemoglobin decreased on Apr 08, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 171.0 lb, was diagnosed with hepatitis c (What is hepatitis c?), depression (What is depression?) and. Infergen dosage: 15 ?g Qd Subcutaneous. During the same period patient was treated with RIBASPHERE (400 MG, 600 MG) (NOT SPECIFIED) (400 Mg Oral, 600 Mg Oral) (View Ribasphere (400 Mg, 600 Mg) (not Specified) Review and Ribasphere (400 Mg, 600 Mg) (not Specified) Label ), CELEXA (10 Mg Qd Oral, 20 Mg Qd Oral) (View Celexa Review and Celexa Label ).